Supplementary Data from Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S1: Approval timeline for key theranostic agents.
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7213345425
